Annual report pursuant to Section 13 and 15(d)

EQUITY (Details 2)

v3.23.1
EQUITY (Details 2) - $ / shares
 4 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Aug. 31, 2021
Aug. 31, 2020
Number Of Shares Outstanding, Granted       74,000,000
Stock Option [Member]        
Number Of Shares Outstanding, Beginning 190,623,000 333,945,000 18,795,000  
Number Of Shares Outstanding, Granted 143,322,000 4,002,000 183,680,000  
Number Of Shares Outstanding, Exercised 0 0 0  
Number Of Shares Outstanding, Forfeited/canceled 0 (24,838,000) (11,852,000)  
Number Of Shares Outstanding, Ending 333,945,000 313,909,000 190,623,000 18,795,000
Number of Shares, Exercisable   131,859,000    
Weighted Average Exercie Price, Beginning $ 35.85 $ 24.45 $ 53.55  
Weighted Average Exercise Price, Granted 9.45 4.89 34.20  
Weighted Average Exercise Price Exercised 0.00 0 0  
Weighted Average Exercise Price, Forfeited/canceled 0.00 25.69 38.55  
Weighted Average Exercie Price, Ending $ 24.45 24.15 $ 35.85 $ 53.55
Weighted Average Exercie Price, Exercisable   $ 29.35    
Weighted Average Life (years), Granted 10 years 10 years 10 years  
Weighted Average Life (years), Forfeited/canceled   8 years 10 months 24 days 8 years 8 months 26 days  
Weighted Average Life (years) 9 years 4 months 9 days 8 years 4 months 28 days 9 years 3 months 7 days 8 years 10 months 24 days
Weighted Average Life (years), Excercisable   8 years 2 months 8 days